Pharmaceutical Preparations · DE · CIK 1370053
Develops antibody product candidates for inflammation and immuno-oncology unmet medical needs
Comparable business profile · signals at a glance
In the 90 days to Mar 27, 2026: 5 sold $5.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 3,662 | $58.62 | $215K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 3,155 | $64.19 | $203K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 3,038 | $65.20 | $198K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 2,592 | $63.35 | $164K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 2,570 | $57.91 | $149K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 1,012 | $62.15 | $63K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 550 | $60.63 | $33K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 490 | $59.62 | $29K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 510 | $56.61 | $29K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 100 | $65.99 | $7K |
| Feb 11, 2026 | Loumeau Eric JCHIEF LEGAL OFFICER | Sell | 10,000 | $54.00 | $540K |
| Jan 15, 2026 | Marquet MagdaDirector | Sell | 9,290 | $48.12 | $447K |
| Jan 15, 2026 | Marquet MagdaDirector | Sell | 1,710 | $48.85 | $84K |
| Jan 8, 2026 | Faga DanielPresident, CEO | Sell | 14,281 | $44.71 | $639K |
| Jan 8, 2026 | Lizzul Paul F.Chief Medical Officer | Sell | 3,650 | $44.71 | $163K |
| Jan 8, 2026 | Mulroy DennisCHIEF FINANCIAL OFFICER | Sell | 2,515 | $44.71 | $112K |
| Jan 8, 2026 | Loumeau Eric JCHIEF LEGAL OFFICER | Sell | 2,210 | $44.71 | $99K |
| Jan 7, 2026 | Faga DanielPresident, CEO | Sell | 9,202 | $45.11 | $415K |
| Jan 7, 2026 | Loumeau Eric JCHIEF LEGAL OFFICER | Sell | 5,281 | $45.38 | $240K |
| Jan 7, 2026 | Lizzul Paul F.Chief Medical Officer | Sell | 2,235 | $45.11 | $101K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.